Ethic Inc. grew its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 13.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,221 shares of the semiconductor company’s stock after acquiring an additional 2,057 shares during the period. Ethic Inc.’s holdings in Synopsys were worth $8,656,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also modified their holdings of SNPS. Brighton Jones LLC grew its stake in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after acquiring an additional 50 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Synopsys by 26.8% in the first quarter. GAMMA Investing LLC now owns 2,790 shares of the semiconductor company’s stock worth $1,196,000 after acquiring an additional 590 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its stake in shares of Synopsys by 8.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 6,748 shares of the semiconductor company’s stock worth $2,894,000 after acquiring an additional 550 shares in the last quarter. Flagship Harbor Advisors LLC grew its stake in shares of Synopsys by 104.0% in the first quarter. Flagship Harbor Advisors LLC now owns 1,324 shares of the semiconductor company’s stock worth $568,000 after acquiring an additional 675 shares in the last quarter. Finally, Asset Management One Co. Ltd. lifted its position in shares of Synopsys by 7.3% during the 1st quarter. Asset Management One Co. Ltd. now owns 76,660 shares of the semiconductor company’s stock worth $32,876,000 after purchasing an additional 5,219 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Buying and Selling at Synopsys
In other news, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares of the company’s stock, valued at approximately $42,181,951.15. This represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Shelagh Glaser sold 3,655 shares of the company’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the sale, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at $9,339,847.09. The trade was a 19.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 over the last ninety days. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Price Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same period last year, the firm earned $3.43 earnings per share. Synopsys’s revenue was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on SNPS. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Stifel Nicolaus decreased their price objective on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Citigroup cut shares of Synopsys from a “neutral” rating to an “underperform” rating in a research report on Wednesday, September 10th. Robert W. Baird reaffirmed a “neutral” rating and set a $535.00 price objective (down from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Needham & Company LLC decreased their price objective on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Ten research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, Synopsys presently has an average rating of “Hold” and a consensus price target of $569.67.
View Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- 5 Top Rated Dividend Stocks to Consider
- Quanta Services: The Backbone of the AI Data Center Push
- Health Care Stocks Explained: Why You Might Want to Invest
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.